Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
HAE Haemonetics
- 77.180
- +1.740+2.31%
Close Dec 23 16:00 ET
- 77.180
- 0.0000.00%
Post 16:00 ET
3.88BMarket Cap32.02P/E (TTM)
77.480High74.490Low652.20KVolume75.110Open75.440Pre Close49.88MTurnover1.31%Turnover Ratio33.70P/E (Static)50.22MShares97.97052wk High4.41P/B3.84BFloat Cap70.25052wk Low--Dividend TTM49.72MShs Float142.110Historical High--Div YieldTTM3.96%Amplitude6.344Historical Low76.483Avg Price1Lot Size
Haemonetics Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 28, 2024 | (Q1)Jun 29, 2024 | (FY)Mar 30, 2024 | (Q4)Mar 30, 2024 | (Q3)Dec 30, 2023 | (Q2)Sep 30, 2023 | (Q1)Jul 1, 2023 | (FY)Apr 1, 2023 | (Q4)Apr 1, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.59%345.51M | 7.98%336.17M | 12.01%1.31B | 12.77%343.29M | 10.14%336.25M | 6.96%318.18M | 19.08%311.33M | 17.67%1.17B | 14.87%304.42M | 305.3M |
| Operating revenue | 8.59%345.51M | 7.98%336.17M | 12.01%1.31B | 12.77%343.29M | 10.14%336.25M | 6.96%318.18M | 19.08%311.33M | 17.67%1.17B | 14.87%304.42M | --305.3M |
| Cost of revenue | 7.04%158.07M | 11.93%161.25M | 11.55%617.51M | 12.97%167.38M | 8.04%158.38M | 5.78%147.67M | 20.87%144.07M | 13.51%553.56M | 15.13%148.17M | 146.59M |
| Gross profit | 9.93%187.44M | 4.58%174.92M | 12.43%691.55M | 12.58%175.91M | 12.07%177.87M | 8.00%170.51M | 17.57%167.27M | 21.68%615.1M | 14.63%156.25M | 158.71M |
| Operating expense | 0.39%135.74M | 18.98%135.17M | 12.80%518.25M | 21.90%147.96M | 14.26%131.89M | 21.65%135.21M | 1.89%113.61M | 5.78%459.45M | 3.64%121.38M | 115.43M |
| Selling and administrative expenses | -7.26%106.95M | 15.79%108.25M | 14.63%431.78M | 24.47%121.68M | 18.01%111.71M | 25.31%115.32M | 1.36%93.49M | 10.74%376.68M | 5.78%97.76M | --94.66M |
| Research and development costs | 30.52%16.53M | 14.24%14.45M | 8.59%54.44M | 1.36%15.86M | 4.54%13.27M | 16.24%12.67M | 16.02%12.65M | 7.12%50.13M | 18.43%15.64M | --12.69M |
| Depreciation amortization depletion | 69.81%12.26M | 66.88%12.47M | -1.87%32.03M | 30.74%10.43M | -14.45%6.91M | -12.15%7.22M | -10.68%7.47M | -31.16%32.64M | -30.56%7.97M | --8.08M |
| -Depreciation and amortization | 69.81%12.26M | 66.88%12.47M | -1.87%32.03M | 30.74%10.43M | -14.45%6.91M | -12.15%7.22M | -10.68%7.47M | -31.16%32.64M | -30.56%7.97M | --8.08M |
| Operating profit | 46.44%51.7M | -25.91%39.76M | 11.34%173.3M | -19.87%27.94M | 6.24%45.98M | -24.46%35.3M | 74.40%53.66M | 118.77%155.65M | 81.64%34.87M | 43.28M |
| Net non-operating interest income expense | -183.00%-6.99M | 436.25%6.96M | 11.02%-13.02M | -148.35%-6.53M | -84.74%-1.95M | 56.44%-2.47M | 60.76%-2.07M | 14.55%-14.63M | 32.10%-2.63M | -1.06M |
| Non-operating interest income | ---- | --6.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 183.00%6.99M | ---- | -11.02%13.02M | 148.35%6.53M | 84.74%1.95M | -56.44%2.47M | -60.76%2.07M | -14.55%14.63M | -32.10%2.63M | --1.06M |
| Other net income (expense) | -2,303.93%-8.42M | 2M | -96.02%382K | |||||||
| Special income (charges) | ---- | ---- | -2,303.93%-8.42M | 423.56%2M | --0 | ---- | ---- | -96.02%382K | --382K | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --10.42M | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
| -Gain on sale of business | ---- | ---- | 423.56%2M | ---- | ---- | ---- | ---- | -96.02%382K | ---- | ---- |
| Income before tax | 36.16%44.7M | -9.45%46.71M | 7.40%151.87M | -28.24%23.41M | 4.27%44.03M | -20.04%32.83M | 102.36%51.59M | 122.23%141.4M | 112.87%32.63M | 42.22M |
| Income tax | 37.22%10.87M | -20.93%8.34M | 31.94%34.31M | -6.04%3.05M | 37.80%12.79M | 0.79%7.92M | 87.79%10.55M | 28.38%26M | -41.94%3.24M | 9.28M |
| Net income | 35.82%33.83M | -6.50%38.37M | 1.87%117.56M | -30.68%20.37M | -5.17%31.24M | -24.97%24.91M | 106.48%41.04M | 166.05%115.4M | 201.64%29.38M | 32.94M |
| Net income continuous Operations | 35.82%33.83M | -6.50%38.37M | 1.87%117.56M | -30.68%20.37M | -5.17%31.24M | -24.97%24.91M | 106.48%41.04M | 166.05%115.4M | 201.64%29.38M | --32.94M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 35.82%33.83M | -6.50%38.37M | 1.87%117.56M | -30.68%20.37M | -5.17%31.24M | -24.97%24.91M | 106.48%41.04M | 166.05%115.4M | 201.64%29.38M | 32.94M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 35.82%33.83M | -6.50%38.37M | 1.87%117.56M | -30.68%20.37M | -5.17%31.24M | -24.97%24.91M | 106.48%41.04M | 166.05%115.4M | 201.64%29.38M | 32.94M |
| Basic earnings per share | 34.69%0.66 | -7.41%0.75 | 2.20%2.32 | -31.15%0.401 | -4.62%0.62 | -24.62%0.49 | 107.69%0.81 | 167.06%2.27 | 205.65%0.5825 | 0.65 |
| Diluted earnings per share | 37.50%0.66 | -7.50%0.74 | 2.23%2.29 | -29.82%0.4 | -4.69%0.61 | -25.00%0.48 | 110.53%0.8 | 166.67%2.24 | 200.00%0.57 | 0.64 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.